News

The US Food and Drug Administration has fully approved a new COVID vaccine option specifically targeting high-risk individuals, including seniors. The protein-based Nuvaxovid vaccine, produced by ...
The most commonly reported adverse events with the AZD1222 COVID-19 vaccine are headache and fatigue, a large-scale active ...
No, this is not true. Vaccines undergo rigorous safety testing and are continuously monitored for adverse events.
Under a new policy announced Tuesday by the Trump administration, only people age 65 and older and children or young adults ...
In recent interviews, Health and Human Services Secretary Robert F. Kennedy Jr. has minimized the risk COVID-19 poses to kids ...
Agency leaders said there was evidence to justify approval only for older people and those with medical conditions. Many ...
Since the COVID-19 pandemic, there has been a decline in U.S. vaccine uptake, while widespread misinformation and distrust ...
Late-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect ...